metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Recomendaciones en el manejo diagnóstico y terapéutico de los enfermos con sí...
Información de la revista
Vol. 27. Núm. 8.
Páginas 473-479 (Enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 27. Núm. 8.
Páginas 473-479 (Enero 2004)
Acceso a texto completo
Recomendaciones en el manejo diagnóstico y terapéutico de los enfermos con síndrome de Budd-Chiari*
Visitas
5121
M. Hernández-Guerra, J.C. García-Pagán***
Autor para correspondencia
jcgarcia@clinic.ub.es

Correspondencia: Dr. J.C. García-Pagán. Laboratorio de Hemodinámica Hepática. Servicio de Hepatología. Hospital Clínic de Barcelona. Villarroel, 170. 08036 Barcelona. España.
, el Grupo Europeo para el Estudio de Enfermedades Vasculares Hepáticas (ENVie) **
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
H.L. Janssen, J.C. García-Pagán, E. Elias, G. Mentha, A. Hadengue, D.C. Valla.
Budd-Chiari syndrome: a review by an expert panel.
J Hepatol, 38 (2003), pp. 364-371
[2.]
J. Ludwig, E. Hashimoto, D.B. McGill, J.A. Van Heerden.
Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome.
Mayo Clin Proc, 65 (1990), pp. 51-55
[3.]
D. Valla, A. Hadengue, M. El Younsi, N. Azar, G. Zeitoun, M.J. Boudet, et al.
Hepatic venous outflow block caused by shortlength hepatic vein stenoses.
Hepatology, 25 (1997), pp. 814-819
[4.]
A.E. Mahmoud, J.T. Wilde, E. Elias.
Budd-Chiari syndrome and factor V Leiden mutation.
Lancet, 345 (1995), pp. 526
[5.]
M.H. Denninger, Y. Chait, N. Casadevall, S. Hillaire, M.C. Guillin, A. Bezeaud, et al.
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.
Hepatology, 31 (2000), pp. 587-591
[6.]
H.L. Janssen, J.R. Meinardi, F.P. Vleggaar, S.H. Van Uum, E.B. Haagsma, F.J. Der Meer, et al.
Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.
Blood, 96 (2000), pp. 2364-2368
[7.]
P. Deltenre, M.H. Denninger, S. Hillaire, M.C. Guillin, N. Casadevall, J. Briere, et al.
Factor V Leiden related Budd-Chiari syndrome.
Gut, 48 (2001), pp. 264-268
[8.]
A. Hadengue, M. Poliquin, V. Vilgrain, J. Belghiti, C. Degott, S. Erlinger, et al.
The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases.
Gastroenterology, 106 (1994), pp. 1042-1047
[9.]
I.R. Wanless, P. Peterson, A. Das, J.K. Boitnott, G.W. Moore, V. Bernier.
Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy.
Hepatology, 12 (1990), pp. 1166-1174
[10.]
J.B. Dilawari, P. Bambery, Y. Chawla, U. Kaur, S.R. Bhusnurmath, H.S. Malhotra, et al.
Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature.
Medicine (Baltimore), 73 (1994), pp. 21-36
[11.]
L. Bolondi, S. Gaiani, B.S. Li, G. Zironi, F. Bonino, M. Brunetto, et al.
Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound.
Gastroenterology, 100 (1991), pp. 1324-1331
[12.]
Y. Chawla, S. Kumar, R.K. Dhiman, S. Suri, J.B. Dilawari.
Duplex Doppler sonography in patients with Budd-Chiari syndrome.
J Gastroenterol Hepatol, 14 (1999), pp. 904-907
[13.]
R. Kane, S. Eustace.
Diagnosis of Budd-Chiari syndrome: comparison between sonography and MR angiography.
Radiology, 195 (1995), pp. 117-121
[14.]
S. Gupta, S. Barter, G.W. Phillips, R.N. Gibson, H.J. Hodgson.
Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome.
Gut, 28 (1987), pp. 242-247
[15.]
L. Kreel, J.W. Freston, D. Clain.
Vascular radiology in the Budd-Chiari syndrome.
Br J Radiol, 40 (1967), pp. 755-759
[16.]
G. Zeitoun, S. Escolano, A. Hadengue, N. Azar, M. El Younsi, A. Mallet, et al.
Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting.
Hepatology, 30 (1999), pp. 84-89
[17.]
V. Vilgrain, M. Lewin, C. Vons, A. Denys, D. Valla, J.F. Flejou, et al.
Hepatic nodules in Budd-Chiari syndrome: imaging features.
[18.]
T.J. Tang, K.P. Batts, P.C. De Groen, B. Van Hoek, E.B. Haagsma, W.C. Hop, et al.
The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome.
J Hepatol, 35 (2001), pp. 338-343
[19.]
D.C. Valla.
The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies.
Hepatology, 38 (2003), pp. 793-803
[20.]
T. Ishiguchi, H. Fukatsu, S. Itoh, K. Shimamoto, S. Sakuma.
Budd-Chiari syndrome with long segmental inferior vena cava obstruction: treatment with thrombolysis, angioplasty, and intravascular stents.
J Vasc Interv Radiol, 3 (1992), pp. 421-425
[21.]
G.S. Raju, M. Felver, J.W. Olin, S.D. Satti.
Thrombolysis for acute Budd-Chiari syndrome: case report and literature review.
Am J Gastroenterol, 91 (1996), pp. 1262-1263
[22.]
S. Sharma, A. Texeira, P. Texeira, E. Elias, J. Wilde, S.P. Olliff.
Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature.
J Hepatol, 40 (2004), pp. 172-180
[23.]
J.r. López RR, K.G. Benner, L. Hall, J. Rosch, C.W. Pinson.
Expandable venous stents for treatment of the Budd-Chiari syndrome.
Gastroenterology, 100 (1991), pp. 1435-1441
[24.]
J.I. Bilbao, J.C. Pueyo, J.M. Longo, M. Arias, J.I. Herrero, A. Benito, et al.
Interventional therapeutic techniques in Budd-Chiari syndrome.
Cardiovasc Intervent Radiol, 20 (1997), pp. 112-119
[25.]
N.C. Fisher, I. McCafferty, M. Dolapci, M. Wali, J.A. Buckels, S.P. Olliff, et al.
Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting.
Gut, 44 (1999), pp. 568-574
[26.]
M.J. Orloff, P.O. Daily, S.L. Orloff, B. Girard, M.S. Orloff.
A 27-year experience with surgical treatment of Budd-Chiari syndrome.
Ann Surg, 232 (2000), pp. 340-352
[27.]
B. Ringe, H. Lang, K.J. Oldhafer, M. Gebel, P. Flemming, A. Georgii, et al.
Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A singlecenter experience with 50 patients.
Hepatology, 21 (1995), pp. 1337-1344
[28.]
A.W. Hemming, B. Langer, P. Greig, B.R. Taylor, R. Adams, E.J. Heathcote.
Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation.
Am J Surg, 171 (1996), pp. 176-180
[29.]
Y. Panis, J. Belghiti, D. Valla, J.P. Benhamou, F. Fekete.
Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries.
Surgery, 115 (1994), pp. 276-281
[30.]
J.B. Bachet, B. Condat, H. Hagége, A. Plessier, J. Belghiti, D. Valla.
Long term survival after portosystemic shunting for Budd-Chiari syndrome. Shunt patency is determinant [resumen].
Hepatology, 38 (2004), pp. 416A
[31.]
A. Ochs, M. Sellinger, K. Haag, G. Noldge, E.W. Herbst, E. Walter, et al.
Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome.
J Hepatol, 18 (1993), pp. 217-225
[32.]
U. Blum, M. Rossle, K. Haag, A. Ochs, H.E. Blum, K.H. Hauenstein, et al.
Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt.
Radiology, 197 (1995), pp. 805-811
[33.]
A. Perello, J.C. García-Pagán, R. Gilabert, Y. Suárez, E. Moitinho, F. Cervantes, et al.
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.
Hepatology, 35 (2002), pp. 132-139
[34.]
G. Halff, S. Todo, A.G. Tzakis, R.D. Gordon, T.E. Starzl.
Liver transplantation for the Budd-Chiari syndrome.
Ann Surg, 211 (1990), pp. 43-49
[35.]
D.P. Slakey, A.S. Klein, A.C. Venbrux, J.L. Cameron.
Budd-Chiari syndrome: current management options.
Ann Surg, 233 (2001), pp. 522-527

Al final del artículo se indican los componentes del Grupo Europeo para el Estudio de Enfermedades Vasculares Hepáticas.

Este documento es una adaptación de las guías clínicas elaboradas por el comité científico del European Network for the Study of Vascular Disorders of the Liver, que se basan en el consenso alcanzado después de una extensa discusión sustentada en una revisión exhaustiva de la bibliografía y en la experiencia personal de los miembros del comité. En aquellas situaciones en las que no haya suficientes datos que permitan emitir recomendaciones basadas en la evidencia, se presentan y discuten las opciones existentes.

Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos